In contrast to these studies, a recently published study reported that RIPK3 deficiency or MLKL deficiency had no impact on inflammation-associated or sporadic colorectal tumor development in mice [53], suggesting that necroptosis is rather irrelevant for CRC development. This evidence concerns the gene MLKL and colorectal carcinoma.